Hetero Biopharma Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Hetero Biopharma's estimated annual revenue is currently $40.3M per year.(i)
  • Hetero Biopharma's estimated revenue per employee is $140,000

Employee Data

  • Hetero Biopharma has 288 Employees.(i)
  • Hetero Biopharma grew their employee count by 22% last year.

Hetero Biopharma's People

NameTitleEmail/Phone

What Is Hetero Biopharma?

Hetero Biopharma - Hope within reach ï‚§ With a philosophy of REACHing every needy patient, expanding aggressively across all regions of emerging markets, ï‚§ GMP certification from leading regulatory bodies in emerging markets, ï‚§ Strategic partnership in emerging markets with regional leaders for increased biosimilar access, 70 + Countries operations started, 50 + Countries dossiers filled, 30 + countries Commercialized. Our mission of REACHing every needy patient globally, we make Complex Biosimilars Affordable, Available and Accessible.

keywords:N/A

N/A

Total Funding

288

Number of Employees

$40.3M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Hetero Biopharma News

2022-03-22 - Hetero Biopharma gets approval to make Sputnik Light Covid vaccine

Hyderabad: Pharma player Hetero announced that its biologics arm 'Hetero Biopharma' has received approval from the Central Drugs Standard...

2022-03-22 - Hetero gets CDSCO nod to make & sell Sputnik Light vaccine in India

Hetero is the first biopharmaceutical company in India to receive manufacturing & marketing (M&M) approval for the product manufactured locally...

2022-03-22 - Hetero gets CDSCO nod to produce, sell Sputnik Light vaccine

Hetero Biopharma, the biologics arm of drugmaker Hetero, has received the Central Drugs Standard Control Organisation's (CDSCO) approval to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$40.3M28833%N/A
#2
$79M29353%N/A
#3
$41M29313%N/A
#4
$41M29313%N/A
#5
$87.3M29425%N/A